Nathaniel S. Gardiner - 26 Feb 2024 Form 4 Insider Report for ENANTA PHARMACEUTICALS INC (ENTA)

Role: Chief Legal Officer
Signature: /s/ Nathaniel S. Gardiner
Issuer symbol: ENTA
Transactions as of: 26 Feb 2024
Net transactions value: +$46,631
Form type: 4
Filing time: 27 Feb 2024, 18:31:52 UTC
Previous filing: 14 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ENTA	Common Stock	Options Exercise	$46,631	+5,187	+7.4%	$8.99	75,688	26 Feb 2024	Direct
holding	ENTA	Common Stock						35,926	26 Feb 2024	By grantor retained annuity trust	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ENTA	Stock Option (Right to Buy)	Options Exercise	$0	-5,187	-6.2%	$0.000000	77,813	26 Feb 2024	Common Stock	5,187	$8.99	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares are held by grantor retained annuity trusts created by the reporting person for the benefit of himself and his two adult children.
F2	Such option became or will become exercisable (subject to the optionholder's continued employment) quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over four years from the date of grant (November 22, 2023).